Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }

Just about every reason to invest in Cineplex Inc. over the past three years has gone horribly wrong. Perhaps simply betting that the pandemic will eventually recede is the only remaining reason.

As many Canadian stocks recover from the market selloff in February and March, Cineplex shares continue to explore new lows, extending a three-year decline that began with dwindling attendance figures and then turned particularly nasty this year when cinemas were closed in response to the pandemic.

The three-year journey for investors who stuck with the stock: A decline of 86 per cent and a once-attractive dividend suspended earlier this year.

Story continues below advertisement

Encouraging developments over this period didn’t last long. The company’s diversification strategy, based on developing Rec Room entertainment and gaming facilities, failed to ignite much interest after Cineplex opened its first location in 2016 and expanded its footprint in 2017. The share price slumped 30 per cent in 2018.

As well, the bet that U.K.-based Cineworld Group PLC would complete its takeover of the Canadian cinema chain this year for $34 a share also failed. Cineworld terminated the agreement in June.

And lastly, the upbeat hope that reopening Canadian movie theatres in August would draw back movie enthusiasts has been dashed by a second wave of COVID-19 infections. In Quebec, the government announced this week that cinemas will close for most of October in a number of populated areas. Cineplex shares slumped about 9 per cent in the days following the announcement, suggesting that the second wave of the pandemic is weighing on optimism.

Intrepid investors who continue to hold the stock or are thinking of scooping up shares on the cheap need something to go right here. That something: that Cineplex can get through the current bout of uncertainty until conditions return to normal.

For encouragement, look at Cineworld, Cineplex’s one-time suitor.

Cineworld tantalized its investors last week with encouraging figures from China, where moviegoing activities have recovered quickly amid relatively few cases of COVID-19, suggesting that the business can make a swift comeback in a postpandemic world.

What’s more, Cineworld has secured US$361-million in additional liquidity, implying it has support. The U.K. company’s share price, though down substantially because of the pandemic, has nearly doubled from its lows in March.

Story continues below advertisement

For Cineplex, the news is similar. The company completed a $316.25-million convertible debenture offering – essentially debt that can be converted into common shares – in July. The offering eased concerns about the terms of its outstanding debt and allowed it to repay $100-million in existing debt.

According to analysts, the offering removes the risk that the company could run out of cash in the near term, and some investors appear to agree: The debentures, which trade on the Toronto Stock Exchange, are valued close to their starting price.

Still, no one is celebrating. Robert Bek, an analyst at CIBC World Markets, in August cut his target price – where he believes the shares will trade in about 12 months – to $10 from $14 previously. (The stock closed at $7.29, up 8 cents on Thursday.) The downgrade came after the company released its second-quarter financial results, which included burning through about $54-million in cash.

The bet here is that Cineplex survives, the pandemic recedes and moviegoers return to theatres, perhaps in greater numbers as consumers embrace normality and look for reasons to leave the house once again.

But given the increasing uncertainty over when that could be, and the fact that Cineplex investors have had their hopes dashed repeatedly in recent years, investors may want to wait for some additional convincing.

Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.

Report an error Editorial code of conduct
Tickers mentioned in this story
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies